Literature DB >> 10945981

Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology.

E Kumaraswamy1, A Malykh, K V Korotkov, S Kozyavkin, Y Hu, S Y Kwon, M E Moustafa, B A Carlson, M J Berry, B J Lee, D L Hatfield, A M Diamond, V N Gladyshev.   

Abstract

Selenium has been implicated in cancer prevention, but the mechanism and possible involvement of selenoproteins in this process are not understood. To elucidate whether the 15-kDa selenoprotein may play a role in cancer etiology, the complete sequence of the human 15-kDa protein gene was determined, and various characteristics associated with expression of the protein were examined in normal and malignant cells and tissues. The 51-kilobase pair gene for the 15-kDa selenoprotein consisted of five exons and four introns and was localized on chromosome 1p31, a genetic locus commonly mutated or deleted in human cancers. Two stem-loop structures resembling selenocysteine insertion sequence elements were identified in the 3'-untranslated region of the gene, and only one of these was functional. Two alleles in the human 15-kDa protein gene were identified that differed by two single nucleotide polymorphic sites that occurred within the selenocysteine insertion sequence-like structures. These 3'-untranslated region polymorphisms resulted in changes in selenocysteine incorporation into protein and responded differently to selenium supplementation. Human and mouse 15-kDa selenoprotein genes manifested the highest level of expression in prostate, liver, kidney, testis, and brain, and the level of the selenoprotein was reduced substantially in a malignant prostate cell line and in hepatocarcinoma. The expression pattern of the 15-kDa protein in normal and malignant tissues, the occurrence of polymorphisms associated with protein expression, the role of selenium in differential regulation of polymorphisms, and the chromosomal location of the gene may be relevant to a role of this protein in cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10945981     DOI: 10.1074/jbc.M004014200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  In silico identification of the sea squirt selenoproteome.

Authors:  Liang Jiang; Qiong Liu; Jiazuan Ni
Journal:  BMC Genomics       Date:  2010-05-10       Impact factor: 3.969

2.  Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanism.

Authors:  Ryuta Tobe; Min-Hyuk Yoo; Noelia Fradejas; Bradley A Carlson; Soledad Calvo; Vadim N Gladyshev; Dolph L Hatfield
Journal:  Biochem J       Date:  2012-08-01       Impact factor: 3.857

Review 3.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

4.  Serum selenium and risk of prostate cancer-a nested case-control study.

Authors:  Ulrike Peters; Charles B Foster; Nilanjan Chatterjee; Arthur Schatzkin; Douglas Reding; Gerald L Andriole; E David Crawford; Stefan Sturup; Stephen J Chanock; Richard B Hayes
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

5.  Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and Apoptosis.

Authors:  Emily C Chiang; Shuren Shen; Seema S Kengeri; Huiping Xu; Gerald F Combs; J Steven Morris; David G Bostwick; David J Waters
Journal:  Dose Response       Date:  2009-12-21       Impact factor: 2.658

Review 6.  Selenoproteins that function in cancer prevention and promotion.

Authors:  Dolph L Hatfield; Min-Hyuk Yoo; Bradley A Carlson; Vadim N Gladyshev
Journal:  Biochim Biophys Acta       Date:  2009-03-09

Review 7.  Selenoproteins in colon cancer.

Authors:  Kristin M Peters; Bradley A Carlson; Vadim N Gladyshev; Petra A Tsuji
Journal:  Free Radic Biol Med       Date:  2018-05-22       Impact factor: 7.376

Review 8.  Selenoproteins: molecular pathways and physiological roles.

Authors:  Vyacheslav M Labunskyy; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

9.  Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.

Authors:  Brian L Lindshield; Nikki A Ford; Kirstie Canene-Adams; Alan M Diamond; Matthew A Wallig; John W Erdman
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

Review 10.  Molecular mechanisms by which selenoproteins affect cancer risk and progression.

Authors:  Pin Zhuo; Alan M Diamond
Journal:  Biochim Biophys Acta       Date:  2009-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.